CTOs on the Move

Gift of Hope

www.giftofhope.org

 
Gift of Hope Organ and Tissue Donor Network is a not-for-profit organ procurement organization that coordinates organ and tissue donation and provides public education on donation in Illinois and northwest Indiana. As one of 58 OPOs that make up the nation’s donation system, we work with 180 hospitals and serve 12 million people in our donation service area. Since 1986, we have saved the lives of more than 23,000 organ transplant recipients and improved the lives of hundreds of thousands of tissue transplant recipients through our efforts.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Edward Marchewka
VP, IT and Quality Services, and Strategic Planning Profile

Similar Companies

Siloam Family Health Center

Siloam Family Health Center is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Concentra Medical with Urgent Care

Concentra Medical with Urgent Care is a Warwick, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cadence Pharmaceuticals

Cadence Pharmaceuticals is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Diego, CA. To find more information about Cadence Pharmaceuticals, please visit www.cadencepharm.com

OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.

Children's Harbor Family Ctr

Children's Harbor Family Ctr is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.